IKCS 2023: New Advances in Metastatic Kidney Cancer IKCS 2023: New Advances in Metastatic Kidney Cancer

Dr Katy Beckermann highlights a new tyrosine kinase inhibitor and the unique collaborative discussions shaping the future of kidney cancer care, as reported at IKCS 2023.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None MDAngle Source Type: news